PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Healios K.K.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (13)

Healios K.K. owes ¥0.68 for every ¥1 it owns. Healios K.K. made a loss in each of the last two years.

Compared with Healthcare companies in Japan · latest annual results Dec 2025.

P/E ratio

268.3

Investors pay ¥268.3 for every ¥1 of Healios K.K.'s yearly profit, higher than 98% of Healthcare companies in Japan.

P/B ratio

4.99

The share price is 4.99 times Healios K.K.'s book value per share, higher than 88% of Healthcare companies in Japan.

Market cap

¥37.7 B

The total market value of all of Healios K.K.'s shares at today's price (share price × number of shares), larger than 60% of Healthcare companies in Japan. PosiCap size class: Mini Cap.

Net worth (book value)

¥7.5 B

What Healios K.K. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

¥55.90

Net worth divided by the number of shares. The share price of ¥279.00 is 5.0 times this, which is the P/B above.

Return on equity (ROE)

4.2%

Healios K.K. earned 4.2% on its shareholders' money over the last year, lower than 65% of Healthcare companies in Japan.

Owes vs Owns

0.68×

Healios K.K. owes ¥0.68 for every ¥1 it owns (moderate), higher than 82% of Healthcare companies in Japan.

Dividend yield

None

Healios K.K. does not currently pay a dividend.

Revenue growth

-81%

Revenue fell 81% in the year to Dec 2025, and grew 5% a year on average over 3 years.

Profit growth

Loss

Healios K.K. made a loss in each of the last two years.

Profit margin

-2131.7%

Healios K.K. lost ¥2132 for every ¥100 of revenue.

Interest cover

Not covered

Healios K.K.'s operating profit did not cover its interest costs in the year to Dec 2025.

Cash vs debt

Net cash

Healios K.K. held ¥3.1 B more cash than debt (net cash) at Dec 2025.

Questions

What is Healios K.K.'s P/E ratio?

Investors pay ¥268.3 for every ¥1 of Healios K.K.'s yearly profit, higher than 98% of Healthcare companies in Japan.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Healios K.K.: ¥37.7 B ÷ ¥7.5 B (30 Jun 2026) = 5.0.

What is Healios K.K.'s return on equity?

Healios K.K. earned 4.2% on its shareholders' money over the last year, lower than 65% of Healthcare companies in Japan.

How much does Healios K.K. owe compared with what it owns?

Healios K.K. owes ¥0.68 for every ¥1 it owns (moderate), higher than 82% of Healthcare companies in Japan.

Does Healios K.K. pay a dividend?

No. Healios K.K. does not currently pay a dividend.

Is Healios K.K.'s revenue growing?

Revenue fell 81% in the year to Dec 2025, and grew 5% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.